Global Cellulite Treatments Market Could Exceed $1.4 Billion by 2026

Stock Information for Helius Medical Technologies Inc. Class A common shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Helius Medical Technologies Inc. Class A common shares

Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.